|
(ÁÖ)¾ÈÆ®·ÎÁ¨ |
¾ÈÀü°ü¸®¾à»ç ä¿ë °ø°í
¼¿ï °¼±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
°æ·Â¹«°ü |
ä¿ë½Ã |
11.28 |
|
|
Çѱ¹MSD À¯ÇÑȸ»ç |
Medical Information Associate(À°¾ÆÈÞÁ÷´ëü±Ù¹«)
¼¿ï Áß±¸ | Çз¹«°ü |
¾à»ç/ÇѾà»ç |
°æ·Â¹«°ü |
ä¿ë½Ã |
03.31 |
|
|
Çѱ¹MSD ÁÖ½Äȸ»ç |
ID/Vaccine MSL ¸ðÁý
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
Çмú/±³À°/»ó´ã |
2³â¡è |
ä¿ë½Ã |
03.11 |
|
|
Çѱ¹Organon |
Çѱ¹Organon Market Access ´ã´çÀÚ ¸ðÁý
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
1³â¡è |
ä¿ë½Ã |
01.15 |
|
|
Çѱ¹Organon |
Çѱ¹Organon-Market Access Specialist 1¸í ¸ðÁý
¼¿ï Á¾·Î±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
2³â¡è |
ä¿ë½Ã |
12.04 |
|
|
¿î¾ÏÇÑÀÇ¿ø |
ÃæºÏ ûÁֽà <<¿î¾ÏÇÑÀÇ¿ø>> ÇѾà»ç ¸ðÁýÇÕ´Ï´Ù.
ÃæºÏ ûÁֽà »ó´ç±¸ | Çз¹«°ü |
¾à»ç/ÇѾà»ç |
°æ·Â¹«°ü |
ä¿ë½Ã |
11.20 |
|
|
µ¿±¹Á¦¾à(ÁÖ) |
Á¦Á¶°ü¸®ÀÚ(Ç°Áú) ¾à»ç ¸ðÁý(°æ·Â 5³â¡è)
ÃæºÏ Áøõ±º | ´ëÇÐ(4³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
5³â¡è |
ä¿ë½Ã |
04.11 |
|
|
ÇÏÀÌÅÍÄ¡¹ø¿ª |
ÀǾàÇÐ Àü¹® ¹ø¿ª»ç(ÇÁ¸®·£¼)¸¦ ¸ðÁýÇÕ´Ï´Ù
Àü±¹ Àü±¹, ÇØ¿Ü ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
˂ȍ |
5³â¡è |
ä¿ë½Ã |
09.01 |
|
|
Çѱ¹MSDµ¿¹°¾àÇ° |
Çѱ¹MSDµ¿¹°¾àÇ° Technical sales manager(¼öÀÇ»ç)¸ðÁý
Àü±¹ ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
°æ·Â¹«°ü |
ä¿ë½Ã |
07.16 |
|
|
½«Ä¿ÄÚ¸®¾Æ |
Healthcare Quality Management(Pharmacist)
°æ±â ±ºÆ÷½Ã | ´ëÇÐ(4³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
3³â¡è |
ä¿ë½Ã |
05.20 |
|
|
½ÎÀÌÁ¨ÄÚ¸®¾Æ(ÁÖ) |
½ÎÀÌÁ¨ÄÚ¸®¾Æ(ÁÖ) ¼öÀÔ°ü¸® ¾à»ç(ÆÄÆ®) ¸ðÁý
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
3³â¡è |
ä¿ë½Ã |
03.03 |
|
|
Çѱ¹MSD À¯ÇÑȸ»ç |
Market access(Price&reimburse)specialist ¸ðÁý
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
±¤°í/È«º¸/PR/»çº¸ |
3³â¡è |
ä¿ë½Ã |
10.29 |
|
|
Çѱ¹MSD À¯ÇÑȸ»ç |
Oncology MSL 2¸í ä¿ë
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
2³â¡è |
ä¿ë½Ã |
10.31 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] Diabetes Medical Lead
¼¿ï ¼Ãʱ¸ | ´ëÇпø(¼®»ç) Á¹¾÷ |
˂ȍ |
°æ·Â¹«°ü |
ä¿ë½Ã |
10.15 |
|
|
Çѱ¹MSD À¯ÇÑȸ»ç |
RA Specialist 2¸í ä¿ë(»êÈÞ´ëü/½ÅÀÔ°¡´É)
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
°æ·Â¹«°ü |
ä¿ë½Ã |
10.14 |
|